The E2F1 transcription factor regulates the expression of genes involved in cell cycle progression, apoptosis and differentiation. More recent findings, including our preliminary data, indicate that E2F1 has additional functions in DNA repair that are independent of transcription. E2F1 is found to accumulate at sites of DNA double-strand breaks as well as UV radiation-induced DNA damage. Localization of E2F1 to damaged DNA requires the phosphorylation of E2F1 on serine 31 by the ATM or ATR kinases and subsequent binding to the TopBP1 protein. At present, the function of E2F1 at sites of DNA damage is unclear and the goal of this proposal is to fill this gap in knowledge. The overall hypothesis of this application is that E2F1 participates in the recruitment of chromatin modifying enzymes and DNA repair factors to sites of damage to directly enhance some forms of DNA repair.
Specific Aim 1 is to determine the mechanism by which E2F1 stimulates nucleotide excision repair of UV-induced damage while Specific Aim 2 is to determine the role of E2F1 in DNA double-strand break repair.
Specific Aim 3 is to determine the physiological relevance of E2F1 in the DNA damage response using a newly developed E2F1 serine 31 mutant knock-in mouse model. Together, these studies will establish new functions for E2F1 in the DNA damage response and reveal novel mechanisms to enhance DNA repair that operate at the level of chromatin structure. These studies are highly significant for understanding the cellular response to many cancer causing agents and well as the response to conventional cancer therapies.

Public Health Relevance

Some DNA damaging agents cause cancer while others are used to treat cancer. Thus, studying the cellular response to DNA damage is crucial for understanding cancer development and the response to therapy. This proposal will study the role of the E2F1 protein in the response to DNA damage, particularly a novel function at sites of damage that directly enhances DNA repair.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA079648-15
Application #
8613310
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
1999-01-18
Project End
2015-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
15
Fiscal Year
2014
Total Cost
$303,097
Indirect Cost
$111,263
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Biswas, Anup Kumar; Mitchell, David L; Johnson, David G (2014) E2F1 responds to ultraviolet radiation by directly stimulating DNA repair and suppressing carcinogenesis. Cancer Res 74:3369-77
Johnson, David G; Dent, Sharon Y R (2013) Chromatin: receiver and quarterback for cellular signals. Cell 152:685-9
Biswas, Anup K; Johnson, David G (2012) Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. Cancer Res 72:13-7
Guo, Ruifeng; Chen, Jie; Mitchell, David L et al. (2011) GCN5 and E2F1 stimulate nucleotide excision repair by promoting H3K9 acetylation at sites of damage. Nucleic Acids Res 39:1390-7
Chen, Jie; Zhu, Feng; Weaks, Regina L et al. (2011) E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle 10:1287-94
Pusapati, Raju V; Weaks, Regina L; Rounbehler, Robert J et al. (2010) E2F2 suppresses Myc-induced proliferation and tumorigenesis. Mol Carcinog 49:152-6
Guo, Ruifeng; Chen, Jie; Zhu, Feng et al. (2010) E2F1 localizes to sites of UV-induced DNA damage to enhance nucleotide excision repair. J Biol Chem 285:19308-15
Paulson, Q X; Pusapati, R V; Hong, S et al. (2008) Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis. Oncogene 27:4954-61
Hong, Sungki; Paulson, Qiwei X; Johnson, David G (2008) E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis. Cell Cycle 7:391-400
Olson, Melissa V; Johnson, David G; Jiang, Hong et al. (2007) Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res 67:4005-9

Showing the most recent 10 out of 27 publications